Keiko Takemoto
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Keiko Takemoto.
Development | 2012
Siok-Lay Tan; Miyuki Nishi; Toshiyuki Ohtsuka; Toshiyuki Matsui; Keiko Takemoto; Asuka Kamio-Miura; Hiroyuki Aburatani; Yoichi Shinkai; Ryoichiro Kageyama
In the developing brain, neural progenitor cells switch differentiation competency by changing gene expression profiles that are governed partly by epigenetic control, such as histone modification, although the precise mechanism is unknown. Here we found that ESET (Setdb1), a histone H3 Lys9 (H3K9) methyltransferase, is highly expressed at early stages of mouse brain development but downregulated over time, and that ablation of ESET leads to decreased H3K9 trimethylation and the misregulation of genes, resulting in severe brain defects and early lethality. In the mutant brain, endogenous retrotransposons were derepressed and non-neural gene expression was activated. Furthermore, early neurogenesis was severely impaired, whereas astrocyte formation was enhanced. We conclude that there is an epigenetic role of ESET in the temporal and tissue-specific gene expression that results in proper control of brain development.
PLOS Pathogens | 2016
Keiko Yasuma; Jun Ichirou Yasunaga; Keiko Takemoto; Kenji Sugata; Yuichi Mitobe; Norihiro Takenouchi; Masanori Nakagawa; Yutaka Suzuki; Masao Matsuoka
Human T-cell leukemia virus type 1 (HTLV-1) infects CD4+ T cells and induces proliferation of infected cells in vivo, which leads to the onset of adult T-cell leukemia (ATL) in some infected individuals. The HTLV-1 bZIP factor (HBZ) gene, which is encoded in the minus strand of HTLV-1, plays critical roles in pathogenesis. In this study, RNA-seq and ChIP-seq analyses using HBZ transduced T cells revealed that HBZ upregulates the expression and promoter acetylation levels of a co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT), in addition to those of regulatory T cells related genes, Foxp3 and Ccr4. TIGIT was expressed on CD4+ T cells from HBZ-transgenic (HBZ-Tg) mice, and on ATL cells and HTLV-1 infected CD4+ T cells of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in vivo. Expression of Blimp1 and IL-10 was upregulated in TIGIT+CD4+ cells of HBZ-Tg mice compared with TIGIT-CD4+ T cells, suggesting the correlation between TIGIT expression and IL-10 production. When CD4+ T cells from HBZ-Tg mice were stimulated with TIGIT’s ligand, CD155, their production of the inhibitory cytokine IL-10 was enhanced. Furthermore, dendritic cells from HBZ-Tg mice produced high levels of IL-10 after stimulation. These data suggest that HBZ alters immune system to suppressive state via TIGIT and IL-10. Importantly, TIGIT suppressed T-cell responses to another HTLV-1 virus protein, Tax, in vitro. Blocking of TIGIT and PD-1 slightly increased anti-Tax T-cell activity in some HAM/TSP patients. These results suggest that HBZ-induced TIGIT on HTLV-1 infected cells impairs T-cell responses to viral antigens. This study shows that HBZ-induced TIGIT plays a pivotal role in attenuating host immune responses and shaping a microenvironment favorable to HTLV-1.
Mechanisms of Development | 1990
Keiko Takemoto; Ikuo Takeuchi; Masao Tasaka
By Northern transfer and in vitro transcription assays, we examined how cAMP controlled the expression of prespore genes, Dp87 and SP96, in disaggregated slug cells of Dictyostelium discoideum. The transcription of these genes was halted soon after disaggregation and the remaining mRNAs were completely lost within 2 h. Addition of cAMP to cells which had lost the mRNAs induced the transcription of these genes, and the mRNAs were re-accumulated after a lag period of 30 min. The cAMP signal was transduced through the cell surface receptor. Protein synthesis was not needed for the induction of the transcription but was required for the accumulation of the mRNAs. We conclude that prespore gene expression is controlled by cAMP in two different ways: direct induction of transcription of the genes, and stabilization of the transcribed mRNAs by a protein(s) synthesized after addition of cAMP.
Nature Communications | 2018
Masaki Kato; Keiko Takemoto; Yoichi Shinkai
Subsets of endogenous retroviruses (ERVs) are derepressed in mouse embryonic stem cells (mESCs) deficient for Setdb1, which catalyzes histone H3 lysine 9 trimethylation (H3K9me3). Most of those ERVs, including IAPs, remain silent if Setdb1 is deleted in differentiated embryonic cells; however they are derepressed when deficient for Dnmt1, suggesting that Setdb1 is dispensable for ERV silencing in somatic cells. However, H3K9me3 enrichment on ERVs is maintained in differentiated cells and is mostly diminished in mouse embryonic fibroblasts (MEFs) lacking Setdb1. Here we find that distinctive sets of ERVs are reactivated in different types of Setdb1-deficient somatic cells, including the VL30-class of ERVs in MEFs, whose derepression is dependent on cell-type-specific transcription factors (TFs). These data suggest a more general role for Setdb1 in ERV silencing, which provides an additional layer of epigenetic silencing through the H3K9me3 modification.Previous studies suggest that DNA methylation is the main mechanism to silence endogenous retroviruses (ERVs) in somatic cells. Here the authors provide evidence that distinctive sets of ERVs are silenced by Setdb1 in different types of somatic cells, suggesting a general function in ERV silencing.
Retrovirology | 2015
Keiko Yasuma; Jun-ichirou Yasunaga; Keiko Takemoto; Kenji Sugata; Norihiro Takenouchi; Masanori Nakagawa; Yutaka Suzuki; Masao Matsuoka
Human T-cell leukemia virus type 1 (HTLV-1) is a causative virus of adult T-cell leukemia (ATL), and inflammatory diseases. HTLV-1 bZIP factor (HBZ) is encoded on the minus strand of HTLV-1, and expressed in all ATL cases. We performed RNA-seq and ChIP-seq using HBZ transduced T cells, and found that expressions of several Treg-related genes, including Foxp3, CD25, CCR4, CCR5, PD-1, NRP1, IKZF family genes, and T-cell immunoglobulin and ITIM domain receptor (Tigit), were upregulated by HBZ. We focused on TIGIT in this study. TIGIT expression was also upregulated in HTLV-1 infected cells in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and CD4+ T cells of ATL patients. HBZ induced the histone modification of the promoter of TIGIT and enhanced its expression. HBZ also enhanced acetylation of H3K18, which is the specific target of p3. HBZ augments transcription of Tigit gene in the presence of PMA/Ionomycin stimulation. Although the detailed mechanism of HBZ mediated activation of Tigit transcription is still unclear, p3 and activated pathway by PMA/Ionomycin is likely involved in its regulation. Furthermore, we analyzed the function of Tigit in HBZ-expressing T cells and CD4+ T cells from HBZ-transgenic mice (HBZ-Tg), and found that stimulation of Tigit with its ligand, PVR, enhanced expression of inhibitory cytokines, such as IL-10, in HBZ-Tg. These results suggest that the enhanced Tigit expression by HBZ may play a key role to modulate the microenvironment where anti-tumor immune response is attenuated by increased expression of IL-10. This environment seems to be associated with the evasion of HTLV-1 infected cells from anti-tumor host immune response and the pathogenesis of HTLV-1 associated inflammatory diseases and ATL.
DNA Research | 1998
Takahiro Morio; Hideko Urushihara; Tamao Saito; Yoshihiro Ugawa; Hideaki Mizuno; Motonobu Yoshida; Ryuji Yoshino; Biswa Nath Mitra; Min Pi; Tomihiro Sato; Keiko Takemoto; Hiroo Yasukawa; Jeffrey G. Williams; Mineko Maeda; Ikuo Takeuchi; Hiroshi Ochiai; Yoshimasa Tanaka
DNA Research | 1996
Hiroji Aiba; Tomoya Baba; Kouji Hayashi; Toshifumi Inada; Katumi Isono; Takeshi Itoh; Hiroaki Kasai; Kaoru Kashimoto; Shigenobu Kimura; Madoka Kitakawa; Masanari Kitagawa; Kozo Makino; Takeyoshi Miki; Kiyoshi Mizobuchi; Hirotada Mori; Tomoko Mori; Kouji Motomura; Shinsuke Nakade; Yoshikazu Nakamura; Hiroko Nashimoto; Yoshitaka Nishio; Taku Oshima; Noriko Saito; Gen-ichi Sampei; Yasushi Seki; Suharnan Sivasundaram; Hideaki Tagami; Jun-ichi Takeda; Keiko Takemoto; Yasushi Takeuchi
DNA Research | 1996
Taku Oshima; Hiroji Aiba; Tomoya Baba; Katsutoshi Fujita; Kouji Hayashi; Atsuko Honjo; Keiichi Ikemoto; Toshifumi Inada; Takeshi Itoh; Miwako Kajihara; Kaoru Kashimoto; Shigenobu Kimura; Masanari Kitagawa; Kouzou Makino; Shinji Masuda; Takeyoshi Miki; Kiyoshi Mizobuchi; Hirotada Mori; Kouji Motomura; Yoshikazu Nakamura; Hiroko Nashimoto; Yoshitaka Nishio; Noriko Saito; Gen-ichi Sampei; Yasushi Seki; Hideaki Tagami; Keiko Takemoto; Chieko Wada; Yoshihiro Yamamoto; Minoru Yano
DNA Research | 1997
Yoshihiro Yamamoto; Hiroji Aiba; Tomoya Baba; Kouji Hayashi; Toshifumi Inada; Katumi Isono; Takeshi Itoh; Sigenobu Kimura; Masanari Kitagawa; Kozo Makino; Takeyoshi Miki; Nobutaka Mitsuhashi; Kiyoshi Mizobuchi; Hirotada Mori; Shinsuke Nakade; Yoshikazu Nakamura; Hiroko Nashimoto; Taku Oshima; Satoshi Oyama; Noriko Saito; Gen-ichi Sampei; Yu-ji Satoh; Suharnan Sivasundaram; Hideaki Tagami; Hideyuki Takahashi; Jun-ichi Takeda; Keiko Takemoto; Kazuyuki Uehara; Chieko Wada; Sayaka Yamagata
Developmental Biology | 2000
Mineko Maeda; Hidekazu Kuwayama; Masako Yokoyama; Keiko Nishio; Takahiro Morio; Hideko Urushihara; Mariko Katoh; Yoshimasa Tanaka; Tamao Saito; Hiroshi Ochiai; Keiko Takemoto; Hiroo Yasukawa; Ikuo Takeuchi
Collaboration
Dive into the Keiko Takemoto's collaboration.
National Institute of Advanced Industrial Science and Technology
View shared research outputsNational Institute of Advanced Industrial Science and Technology
View shared research outputs